Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PoD Trial in hormone refractory prostate cancer
ISRCTN54716369Phase 3Completed
- Sponsor
- Record Provided by the NHSTCT Register - 2006 Update - Department of Health
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dexamethasone and prednisolone in castration-resistant prostate cancer (CRPC) (3 arms), sponsored by Record Provided by the NHSTCT Register - 2006 Update - Department of Health. Primary endpoint: PSA response rate. Started Feb 2006; status: completed.
02
Drugs
dexamethasoneprednisolone
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on ISRCTN54716369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54716369.